{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:04:23Z","timestamp":1783699463336,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81961128002"],"award-info":[{"award-number":["81961128002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>During the coronavirus disease 2019 (COVID-19) pandemic, seasonal influenza activity declined globally and remained below previous seasonal levels, but intensified in China since 2021. Preventive measures to COVID-19 accompanied by different epidemic characteristics of influenza in different regions of the world. To better respond to influenza outbreaks under the COVID-19 pandemic, we analyzed the epidemiology, antigenic and genetic characteristics, and antiviral susceptibility of influenza viruses in the mainland of China during 2020\u20132021.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Respiratory specimens from influenza like illness cases were collected by sentinel hospitals and sent to network laboratories in Chinese National Influenza Surveillance Network. Antigenic mutation analysis of influenza virus isolates was performed by hemagglutination inhibition assay. Next-generation sequencing was used for genetic analyses. We also conducted molecular characterization and phylogenetic analysis of circulating influenza viruses. Viruses were tested for resistance to antiviral medications using phenotypic and\/or sequence-based methods.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the mainland of China, influenza activity recovered in 2021 compared with that in 2020 and intensified during the traditional influenza winter season, but it did not exceed the peak in previous years. Almost all viruses isolated during the study period were of the B\/Victoria lineage and were characterized by genetic diversity, with the subgroup 1A.3a.2 viruses currently predominated. 37.8% viruses tested were antigenically similar to reference viruses representing the components of the vaccine for the 2020\u20132021 and 2021\u20132022 Northern Hemisphere influenza seasons. In addition, China has a unique subgroup of 1A.3a.1 viruses. All viruses tested were sensitive to neuraminidase inhibitors and endonuclease inhibitors, except two B\/Victoria lineage viruses identified to have reduced sensitivity to neuraminidase inhibitors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Influenza activity increased in the mainland of China in 2021, and caused flu season in the winter of 2021\u20132022. Although the diversity of influenza (sub)type decreases, B\/Victoria lineage viruses show increased genetic and antigenic diversity. The world needs to be fully prepared for the co-epidemic of influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus globally.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40249-022-01002-x","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T13:04:58Z","timestamp":1656507898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Epidemiological and virological surveillance of influenza viruses in China during 2020\u20132021"],"prefix":"10.1186","volume":"11","author":[{"given":"Wei-juan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-hui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-ju","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-xu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-jiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-ran","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"issue":"10127","key":"1002_CR1","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","volume":"391","author":"AD Luliano","year":"2018","unstructured":"Luliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Global Seasonal Influenza-associated Mortality Collaborator Network, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285\u2013300.","journal-title":"Lancet"},{"issue":"3","key":"1002_CR2","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.2105\/AJPH.2012.301137","volume":"103","author":"W Paul Glezen","year":"2013","unstructured":"Paul Glezen W, Schmier JK, Kuehn CM, Ryan KJ, Oxford J. The burden of influenza B: a structured literature review. Am J Public Health. 2013;103(3):e43-51.","journal-title":"Am J Public Health"},{"issue":"4","key":"1002_CR3","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1080\/21645515.2015.1111494","volume":"12","author":"M Tafalla","year":"2016","unstructured":"Tafalla M, Buijssen M, Geets R, Vonk N-S. A comprehensive review of the epidemiology and disease burden of Influenza B in 9 European countries. Hum Vaccin Immunother. 2016;12(4):993\u20131002.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"1002_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/viro.2002.1719","volume":"303","author":"MW Shaw","year":"2002","unstructured":"Shaw MW, Xu X, Li Y, Normand S, Ueki RT, Kunimoto GY, et al. Reappearance and global spread of variants of influenza B\/Victoria\/2\/87 lineage viruses in the 2000\u20132001 and 2001\u20132002 seasons. Virology. 2002;303(1):1\u20138.","journal-title":"Virology"},{"issue":"1","key":"1002_CR5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1073\/pnas.1916585116","volume":"117","author":"RK Virk","year":"2020","unstructured":"Virk RK, Jayakumar J, Mendenhall IH, Moorthy M, Lam P, Linster M, et al. Divergent evolutionary trajectories of influenza B viruses underlie their contemporaneous epidemic activity. Proc Natl Acad Sci USA. 2020;117(1):619\u201328.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"1002_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2807\/1560-7917.ES.2018.23.13.18-00146","volume":"23","author":"C Adlhoch","year":"2018","unstructured":"Adlhoch C, Snacken R, Melidou A, Ionescu S, Penttinen P, The European Influenza Surveillance Network. Dominant influenza A(H3N2) and B\/Yamagata virus circulation in EU\/EEA, 2016\/17 and 2017\/18 seasons, respectively. Euro Surveill. 2018;23(13):18\u201300146.","journal-title":"Euro Surveill"},{"issue":"RR-10","key":"1002_CR7","first-page":"1","volume":"55","author":"NM Smith","year":"2006","unstructured":"Advisory Committee on Immunization Practices, Smith NM, Bresee JS, Shay DK, Uyeki TM, Cox NJ, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-10):1\u201342.","journal-title":"MMWR Recomm Rep"},{"issue":"8","key":"1002_CR8","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/infdis\/jiy723","volume":"220","author":"JM Ferdinands","year":"2019","unstructured":"Ferdinands JM, Gaglani M, Martin ET, Middleton D, Monto AS, Murthy K, et al. Prevention of influenza hospitalization among adults in the United States, 2015\u20132016: results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). J Infect Dis. 2019;220(8):1265\u201375.","journal-title":"J Infect Dis"},{"issue":"1","key":"1002_CR9","first-page":"E28","volume":"57","author":"V Tisa","year":"2016","unstructured":"Tisa V, Barberis I, Faccio V, Paganino C, Trucchi C, Martini M, et al. Quadrivalent influenza vaccine: a new opportunity to reduce the influenza burden. J Prev Med Hyg. 2016;57(1):E28-33.","journal-title":"J Prev Med Hyg"},{"issue":"11","key":"1002_CR10","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1093\/cid\/ciu664","volume":"59","author":"T Heikkinen","year":"2014","unstructured":"Heikkinen T, Ikonen N, Ziegler T. Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999\u20132012. Clin Infect Dis. 2014;59(11):1519\u201324.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1002_CR11","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41467-021-21157-9","volume":"12","author":"QS Huang","year":"2021","unstructured":"Huang QS, Wood T, Jelley L, Jennings T, Jefferies S, Daniells K, et al. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat Commun. 2021;12(1):1001.","journal-title":"Nat Commun"},{"issue":"5","key":"1002_CR12","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/irv.12866","volume":"15","author":"KL Laurie","year":"2021","unstructured":"Laurie KL, Rockman S. Which influenza viruses will emerge following the SARS-CoV-2 pandemic? Influenza Other Respir Viruses. 2021;15(5):573\u20136.","journal-title":"Influenza Other Respir Viruses"},{"key":"1002_CR13","unstructured":"World Health Organization. Recommended composition of influenza virus vaccines for use in the 2022 southern hemisphere influenza season. 2021. https:\/\/www.who.int\/publications\/m\/item\/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2021-southern-hemisphere-influenza-season. Accessed 24 Sept 2021."},{"key":"1002_CR14","unstructured":"World Health Organization. Recommended composition of influenza virus vaccines for use in the 2022\u20132023 northern hemisphere influenza season. 2022. https:\/\/www.who.int\/publications\/m\/item\/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2022-2023-northern-hemisphere-influenza-season. Accessed 25 Feb 2022."},{"issue":"5","key":"1002_CR15","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1128\/JCM.03265-13","volume":"52","author":"B Zhou","year":"2014","unstructured":"Zhou B, Lin X, Wang W, Halpin RA, Bera J, Stockwell TB, et al. Universal influenza B virus genomic amplification facilitates sequencing, diagnostics, and reverse genetics. J Clin Microbiol. 2014;52(5):1330\u20137.","journal-title":"J Clin Microbiol"},{"issue":"39","key":"1002_CR16","first-page":"369","volume":"87","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. Meetings of the WHO working group on surveillance of influenza antiviral susceptibility\u2014Geneva, November 2011 and June 2012. Wkly Epidemiol Rec. 2012;87(39):369\u201374.","journal-title":"Wkly Epidemiol Rec"},{"issue":"4","key":"1002_CR17","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/molbev\/mst010","volume":"30","author":"K Katoh","year":"2013","unstructured":"Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013;30(4):772\u201380.","journal-title":"Mol Biol Evol"},{"issue":"3","key":"1002_CR18","doi-asserted-by":"publisher","first-page":"e9490","DOI":"10.1371\/journal.pone.0009490","volume":"5","author":"MN Price","year":"2010","unstructured":"Price MN, Dehal PS, Arkin AP. FastTree 2\u2014approximately maximum-likelihood trees for large alignments. PLoS ONE. 2010;5(3):e9490.","journal-title":"PLoS ONE"},{"key":"1002_CR19","unstructured":"World Health Organization. Recommended composition of influenza virus vaccines for use in the 2020\u20132021 northern hemisphere influenza season. 2020. https:\/\/www.who.int\/publications\/m\/item\/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2020-2021-northern-hemisphere-influenza-season. Accessed 28 Feb 2020."},{"key":"1002_CR20","unstructured":"World Health Organization. Recommended composition of influenza virus vaccines for use in the 2021\u20132022 northern hemisphere influenza season. 2021. https:\/\/www.who.int\/publications\/m\/item\/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2021-2022-northern-hemisphere-influenza-season. Accessed 26 Feb 2021."},{"issue":"1","key":"1002_CR21","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1080\/22221751.2019.1648183","volume":"8","author":"W Shi","year":"2019","unstructured":"Shi W, Ke C, Fang S, Li J, Song H, Li X, et al. Co-circulation and persistence of multiple A\/H3N2 influenza variants in China. Emerg Microbes Infect. 2019;8(1):1157\u201367.","journal-title":"Emerg Microbes Infect"},{"issue":"44","key":"1002_CR22","doi-asserted-by":"publisher","first-page":"856","DOI":"10.46234\/ccdcw2020.228","volume":"2","author":"WJ Huang","year":"2020","unstructured":"Huang WJ, Cheng YH, Chen T, Li XY, Tan MJ, Wei HJ, et al. Characterization of influenza viruses\u2014China, 2019\u20132020. China CDC Weekly. 2020;2(44):856\u201361.","journal-title":"China CDC Weekly"},{"issue":"44","key":"1002_CR23","doi-asserted-by":"publisher","first-page":"918","DOI":"10.46234\/ccdcw2021.224","volume":"3","author":"WJ Huang","year":"2021","unstructured":"Huang WJ, Li XY, Tan MJ, Cheng YH, Chen T, Wei HJ, et al. Epidemiological and virological surveillance of seasonal influenza viruses\u2014China, 2020\u20132021. China CDC Wkly. 2021;3(44):918\u201322.","journal-title":"China CDC Wkly"},{"issue":"8","key":"1002_CR24","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s007050050399","volume":"143","author":"R Nerome","year":"1998","unstructured":"Nerome R, Hiromoto Y, Sugita S, Tanabe N, Ishida M, Matsumoto M, et al. Evolutionary characteristics of influenza B virus since its first isolation in 1940: dynamic circulation of deletion and insertion mechanism. Arch Virol. 1998;143(8):1569\u201383.","journal-title":"Arch Virol"},{"issue":"Pt 9","key":"1002_CR25","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1099\/0022-1317-82-9-2169","volume":"82","author":"N Nakagawa","year":"2001","unstructured":"Nakagawa N, Kubota R, Nakagawa T, Okuno Y. Antigenic variants with amino acid deletions clarify a neutralizing epitope specific for influenza B virus Victoria group strains. J Gen Virol. 2001;82(Pt 9):2169\u201372.","journal-title":"J Gen Virol"},{"key":"1002_CR26","doi-asserted-by":"publisher","first-page":"105281","DOI":"10.1016\/j.antiviral.2022.105281","volume":"200","author":"EA Govorkova","year":"2022","unstructured":"Govorkova EA, Takashita E, Daniels RS, Fujisaki S, Presser LD, Patel MC, et al. Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018\u20132020. Antivir Res. 2022;200:105281.","journal-title":"Antivir Res"},{"issue":"5","key":"1002_CR27","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1128\/AAC.02628-13","volume":"58","author":"AJ Burnham","year":"2014","unstructured":"Burnham AJ, Baranovich T, Marathe BM, Armstrong J, Webster RG, Govorkova EA. Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y. Antimicrob Agents Chemother. 2014;58(5):2718\u201330.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-022-01002-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40249-022-01002-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-022-01002-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T13:16:31Z","timestamp":1656508591000},"score":1,"resource":{"primary":{"URL":"https:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-022-01002-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1002"],"URL":"https:\/\/doi.org\/10.1186\/s40249-022-01002-x","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"29 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The National Health Commission deemed the data collection for this surveillance to be part of the continuing public health investigation and exempt from institutional review board assessment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have agreed with the publication of this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}